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Les temps d’attente régionaux pour les patients atteints d’un cancer
cutané non mélanome dans le sud-ouest de l’Ontario

Stacy Fan, MD1 , Jesse Hackett, MD1, Kristina Lutz, MD1,2,
Graham Heaton, MD1,3, Caitlin Symonette, MSc, MD1,
and Aaron Grant, MD1

Abstract
Background: Nonmelanoma skin cancer (NMSC) affects many Canadians. Although morbidity and mortality are rare, the
burden to patients and the health-care system is significant. This study aims to evaluate current plastic surgery wait times and care
pathways for patients with NMSC in Southwestern Ontario. Methods: A retrospective chart review of 225 patients treated in
Ontario from 2015 to 2018 was conducted. Inclusion criteria included patients with an NMSC managed with surgical excision.
Referral information was compared. Primary outcomes were wait times: from referral to consultation, referral to excision, and
consultation to excision. Data were analyzed using Student t test with equal variance. Results: One-hundred forty-three patients
were included from the academic cohort and 82 from the community cohort. Referrals to academic and community surgeons
included lesion location (90% and 97.6%, respectively), but less frequently included size (18% and 29.2%, respectively). Most
referrals to academic surgeons included biopsy results (78.6%), as opposed to community referrals (25.6%). Patients in the
academic cohort waited 15.3 + 12.7 weeks from referral to consultation, and 15.7 + 13 weeks from referral to excision. Patients
from the community cohort waited significantly shorter periods of 4.9 + 3.1 (P < .001) and 11.7 + 9.9 weeks (P ¼ .016),
respectively. However, patients of the academic cohort waited 2.4 + 7.1 weeks from consultation to excision, while patients in
the community cohort waited 6.7 + 9.6 weeks (P < .001). Rates of negative peripheral margins on pathology were similar
between groups, at 89.5% of the academic cohort and 88.9% of the community cohort. Deep margins were positive 5.7% of the
time at the academic sites and 6.2% of the time in the community. Conclusions: Patients referred to academic centres waited
significantly longer periods of time in several parameters compared to those referred to a community surgeon. However, academic surgeons often had expedited consultation-to-excision time frame. This study provides important data for future quality
improvement initiatives in NMSC care.
Résumé
Historique : De nombreux Canadiens ont un cancer cutané non mélanome (CCNM). Bien que la morbidité et la mortalité soient
rares, le fardeau est important pour les patients et le système de santé. La présente étude a été conçue pour évaluer les temps
d’attente et les trajectoires de soins en chirurgie plastique pour les patients du sud-ouest de l’Ontario ayant un CCNM.
Méthodologie : Les chercheurs ont réalisé une analyse rétrospective des dossiers de 225 patients traités de 2015 à 2018 en
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Ontario. Un CCNM traité par excision chirurgicale faisait partie des critères d’inclusion. Les chercheurs ont comparé les données
d’adressage vers la chirurgie. Les résultats cliniques primaires étaient les temps d’attente entre l’adressage et la consultation, entre
l’adressage et l’excision ainsi qu’entre la consultation et l’excision. Les chercheurs ont analysé les données au moyen du test de
Student de variance égale. Résultats : Au total, 143 patients ont fait partie de la cohorte universitaire et 82, de la cohorte
communautaire. L’adressage vers des chirurgiens universitaires ou communautaires découlait du siège de la lésion (90 % et 97,6 %,
respectivement) et, à une moindre fréquence, de sa dimension (18,6 % et 29,2 %, respectivement). La plupart des adressages vers
des chirurgiens universitaires incluaient les résultats de biopsies (78,6 %), contrairement à celui vers des chirurgiens communautaires (25,6 %). Les patients de la cohorte universitaire ont attendu 15,3 + 12,7 semaines entre l’adressage et la consultation,
et 15,7 + 13 semaines entre l’adressage et l’excision. Les patients de la cohorte communautaire ont attendu beaucoup moins
longtemps, soit 4,9 + 3,1 (P < 0,001) et 11,7 + 9,9 semaines (P ¼ 0,016), respectivement. Cependant, les patients de la cohorte
universitaire ont attendu 2,4 + 7,1 semaines entre la consultation et l’excision, et ceux de la cohorte communautaire,
6,7 + 9,6 semaines (P < 0,001). À la pathologie, le taux de marges périphériques négatives était semblable entre les groupes, se
situant à 89,5 % dans la cohorte universitaire et à 88,9 % dans la cohorte communautaire. Les marges profondes étaient positives
dans 5,7 % des cas en milieu universitaire et dans 6,2 % des cas dans la communauté. Conclusions : Les patients adressés à des
centres universitaires attendaient considérablement plus longtemps à l’égard de plusieurs paramètres par rapport à ceux adressés
à un chirurgien communautaire. Cependant, les chirurgiens universitaires réduisaient souvent la période entre la consultation et
l’excision. La présente étude fournit des données importantes en vue de prochaines initiatives d’amélioration de la qualité des
soins du CCNM.
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Introduction
Nonmelanoma skin cancer (NMSC) is one of the most common
clinical presentations encountered by plastic surgeons who play
an essential role in the definitive management of these patients.
In 2014, NMSC accounted for over 40% of new cancer diagnoses in Canada.1 One in 8 Canadians will develop basal cell
carcinoma (BCC) in his or her lifetime, and 1 in 20 will develop
squamous cell carcinoma (SCC).2
Unfortunately, care pathways of patients with NMSC in
Ontario are poorly understood as limited research has been
conducted. Patients with NMSC currently follow an unclear
and often complicated care plan. Most commonly, they are
referred to a dermatologist by a general practitioner and then
onto a surgeon. At each stage of care, there are variable wait
times for the assessment and management of a single lesion. A
multidisciplinary team approach would be beneficial along
with access to waitlist times and specialist’s availabilities. This
may optimize appropriate triaging of patients to ensure timely
treatment by a qualified specialist.
Additionally, there is a lack of standard method of referral.
For instance, referrals sent to specialists often contain inconsistent information (such as size and location of the lesion,
whether or not a biopsy has already been completed), which
in the limitations of the current system makes it difficult to
triage the referrals. In an ideal framework, NMSC care would
be coordinated to eliminate barriers such as this and improve
patient accessibility.
Aside from the burden to our health-care system, there are
also significant implications for patients with regard to morbidity and potential mortality, although NMSC is rarely associated with death. There are notable psychosocial effects on a
patients ultimately affecting quality of life.3 Nonmelanoma

skin cancer frequently affects cosmetically sensitive areas and
patients may worry about scarring or disfigurement, feel anxious about a cancerous lesion, and have concerns about recurrence.4,5 Presently, the literature has mixed results on whether
longer time to excision is related to increased lesion size6,7;
however, it is important to remember that lack of statistical
significance does not negate clinical significance.
There is increasing demand for timely access to cancer treatment, including NMSC, in the Canadian health-care system.
Quality improvement initiatives are necessary to ensure optimal delivery of patient care. Plastic surgeons should be at the
forefront of these quality improvement initiatives for patients
with NMSC. In Ontario, the provincial cancer agency Cancer
Care Ontario is moving toward quality-based funding for many
cancer disease sites including NMSC.8 In a quality-based funding structure, health-care dollars follow the patient after diagnosis, as opposed to a global budget for care. This model is
purported to provide opportunity for process improvements,
clinical re-design, improved patient outcomes, enhanced
patient experience, and potential health system cost-savings.8
Quality initiatives such as this require understanding current
care pathways for these patients.
Currently, only 5 Canadian provinces (Alberta, British
Columbia, Manitoba, New Brunswick, and Saskatchewan)
have a cancer registry that routinely includes NMSC data.9
Unfortunately, this does not yet exist in Ontario. The information of NMSC is hard to collect since patients are diagnosed
and treated in numerous settings. Although difficult, it is
important to include NMSC in data collection since it is such
a high-volume problem with a variety of stakeholders, including patients; a variety of health-care providers involved such as
plastic surgeons, general practitioners, and dermatologists; and
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the health-care system itself. Without a pooled resource, it
becomes challenging to understand the clinical picture of this
disease state. To further complicate matters, there is inconsistent
data collection between health-care providers, and consequently
inaccurate estimation of the financial burden. Including NMSC
data in current cancer registries would improve our current
understanding of epidemiology, trends, overall health-care burden (ie, to health-care providers and overall financial burden),
resource allocation, and public health strategies.
The purpose of this study is to understand current wait times
and the care pathway that is involved when a patient is referred
to local academic and community plastic surgeons (affiliated
with Western University) with a provisional diagnosis of NMSC.
We aim to define various wait times (referral to consultation,
consultation to treatment, and referral to treatment) and secondary outcome measures (including information included in referrals and histologic data at lesion excision) of patients with
clinically suspected or documented NMSC and how they are
managed by plastic surgeons in Southwestern Ontario.

7
Table 1. Patient Demographics.

Total patients included
Males
Females
Average age (years)
Average distance from clinic (km)

Academic Centre

Community

143
87
56
72 + 12
21.6

82
37
45
70.9 + 13.3
43.7

skin cancers referred), factors around definitive treatment (any
barriers to timely treatment, location of lesion, clinical margins
recorded, type of suture used for closure, type of closure, and
number of excisions completed), histologic information (pathologic diagnosis, size of specimen, deep and peripheral margins), and follow-up information.

Statistical Analysis

The study was approved by the Western University
Research Ethics Board (REB #110840) and Lawson Health
Sciences. A retrospective chart review was performed on
225 patients who underwent surgical excision of an NMSC
by plastic surgeons within the Division of Plastic and
Reconstructive Surgery at Western University between
January 1, 2015, and January 24, 2018.

Data were then analyzed to assess our primary outcome of wait
times (from biopsy, to referral, to consultation, and ultimately
lesion excision) and secondary outcomes of information
included in referrals (size and location of lesion, biopsy results)
and histologic data at lesion excision. Statistical analysis was
performed using Student t test to test the null hypothesis that
patients would wait a similar amount of time from referral to
consultation, referral to excision, and consultation to excision
between groups. Z test comparison of proportions was used to
compare information included in referrals. The level of significance was set to .05.

Inclusion Criteria

Results

Patients referred to the practices of plastic surgeons with a
provisional diagnosis of an NMSC in both our academic
(London Health Sciences Centre and St. Joseph’s Health Centre in London, Ontario) and affiliated community hospitals
(Windsor Regional Hospital and Stratford General Hospital)
for surgical excision were included in our study. Patients who
underwent lesion excision during the time period were
included. One lesion per patient was included in our analysis.

Demographics

Materials and Methods

Exclusion Criteria
Patients with an alternate clinical diagnosis than NMSC,
incomplete medical records, prior history of radiation for skin
cancer to the anatomic site of the current referral, and those
with a genetic predisposition to NMSC (eg, xeroderma pigmentosum and Gorlin syndrome) were excluded from our study.

Chart Review
Charts were reviewed for demographic information (age, gender, distance from home to clinic), past medical history (including risk factors for NMSC, medications), referral information
(date of referral, time from referral to consultation, type of
lesion, description of lesion, suspected clinical diagnosis, size
of lesion, biopsy information [SCC or BCC], and number of

Patient cohorts from 5 staff surgeons were included in this
study. Demographic data are illustrated in Table 1. Within the
academic cohort, 143 patients from 3 staff surgeons were
included. Within the community cohort, 82 patients from 2
staff surgeons were included. The community cohort included
patients were seen by surgeons at Windsor Regional Hospital
or Stratford General Hospital.
Patients seen in London lived significantly closer to clinic
than those in the community cohort (P < .001). Occupation was
not recorded for most patients seen at the academic centre
(81.1%, n ¼ 116). Of those recorded (n ¼ 27), 22 (81.5%)
patients had an occupation without significant sun exposure,
3 (11.1%) had significant sun exposure, and 2 (7.4%) were
farmers. In the community, patient occupation was not
recorded in 69.5% of cases. Of those recorded (n ¼ 25),
most patients had an occupation without sun exposure (64%,
n ¼ 16), 2 (8%) patients had an occupation with sun exposure
such as landscaping work, and 7 (28%) patients were farmers.

Wait Times
Wait times between various parameters such as referral to consultation, referral to excision, consultation to excision, and
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Figure 1. The average number of weeks patients waited between the
date of referral and date of consultation in both the academic and
community cohorts. Standard error of mean plotted. Asterisk
indicates statistical significance (P < .05).
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Figure 4. The average number of weeks patients waited between the
date of biopsy and date of excision in both the academic and community cohorts. Standard error of mean plotted.

biopsy to excision were calculated. Patients from the academic
cohort waited an average of 15.3 + 12.7 weeks from referral to
consultation. In comparison, patients who saw a community
surgeon only waited 4.9 + 3.1 weeks (P < .001; Figure 1). The
academic cohort waited 15.7 + 13 weeks from referral to
excision. Patients referred to a community surgeon waited a
significantly shorter amount of time, with an average of 11.7 +
9.9 weeks (P ¼ .016; Figure 2). The average time elapsed from
consultation to excision was 2.4 + 7.1 weeks in the academic
cohort, in comparison to the community cohort at 6.7 + 9.6
weeks (P < .001; Figure 3). Patients waited a similar amount of
time between biopsy and excision, at 19.8 + 18.4 and 14.2 +
13.8 weeks, respectively (Figure 4).

Figure 2. The average number of weeks patients waited between the
date of referral and date of excision in both the academic and community cohorts. Standard error of mean plotted. Asterisk indicates
statistical significance (P < .05).

Figure 3. The average number of weeks patients waited between the
date of consultation and date of excision in both the academic and
community cohorts. Standard error of mean plotted. Asterisk
indicates statistical significance (P < .05).

Referral Information
Within the academic cohort (n ¼ 143), the majority of patients
were referred for a clinically suspected BCC (n ¼ 83), followed
by SCC (n ¼ 41) and unknown lesion (n ¼ 16). Of the 143
patients, 3 did not require a new referral since he or she was
already known to the surgeon. A similar trend in referrals was
seen in the community (n ¼ 82) with regard to type of suspected lesion. Most patients were referred for clinically suspected BCC (n ¼ 44), followed by SCC (n ¼ 17) and unknown
lesion (n ¼ 13). There were also 4 referrals made for alternate
diagnoses, including keratoacanthoma, keratin horn, cyst, and
tumour.
Within the academic group, 110 (78.6%) referrals included
biopsy-proven lesions. In contrast to the academic group, the
minority of referrals received in the community included a
biopsy result (25.6%, n ¼ 21, P < .0001). Overall, 79.1% of
excisions by the academic surgeons underwent biopsy prior to
excision (including those with biopsies at referral and those
who underwent biopsy after consultation), in comparison to
58.5% of patients who underwent biopsy prior to excision in
the community (P ¼ .00003; Figure 5).
The majority of new referrals to the academic centres
included a description of the lesion location (90%, n ¼ 126)
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community. The average clinical margin taken was similar
between sites, at 2.96 mm on average in the academic centre
and 2.89 mm on average in the community. Additionally, rates
of negative peripheral margins on pathology were similar
between groups, at 89.5% of the academic cohort and 88.9%
of the community cohort. Deep margins were positive 5.7% of
the time at the academic sites and 6.2% of the time in the
community.

Discussion

Figure 5. Proportion of patients who underwent biopsy of lesion
prior to excision.

in comparison to 97.5% (n ¼ 80) of referrals made to the
community. Additionally, a similar proportion of patients
referred to academic centres and the community included
a description of the lesion size (18.6% [n ¼ 26] and 29.2%
[n ¼ 24], respectively).
Overall, 130 (90.9%) patients from the academic group were
referred for a new lesion, 8 (5.6%) for a recurrence, and 5
(3.5%) for re-excision for positive margins. Some patients
(22.9%, n ¼ 32) were referred for multiple lesions. Most
patients referred had a previous history of skin cancer
(55.7%, n ¼ 78). Thirty-three patients were reported to have
specific risk factors for NMSC, including a history of immunosuppression, excessive sun exposure, blistering sunburns, or
premalignant lesions.
Within the community cohort, most patients were referred for
a new suspected lesion (85.4%, n ¼ 70). The remaining patients
were referred for suspected recurrence (14.6%, n ¼ 12). Community surgeons did not receive any referrals for re-excision of
lesions with positive margins. The majority of patients did not
have a previous history of skin cancer (54.9%, n ¼ 45). Only
26 patients were noted to not have any risk factors for developing NMSC. Most patients were referred for single lesions
(82.9%, n ¼ 68).

Biopsy/Histologic Data
Most lesions were excised from the head and neck region
(Figure 6). Referral information for type of clinically suspected
lesion or biopsy-proven lesions was consistent with histologic
results after lesion excision in 119 (83.2%) patients in the academic
cohort and 45 (54.9%) patients in the community cohort. Basal cell
carcinomas were more prevalent than SCCs in both cohorts (academic: 47.9% vs 42.9%; community 53.7% vs 30.5%, respectively). Within the academic centres, 1.4% of excised lesions
showed no malignancy and 4.3% of them showed dermal scar,
in comparison to the community where 8.5% of lesions showed
no malignancy and 4.9% of them showed dermal scar.
Clinical margins were noted in 106 (74.6%) operative notes
from the academic surgeons in comparison to 72 (90%) in the

The prevalence of NMSCs has been steadily increasing over
the past 40 years.10 With an aging Canadian population, the
public health-care system will be required to shoulder the extra
burden of managing this common disease. Efforts should be
made to optimize care strategies should and begins with understanding current practice. This study collected data on NMSC
treatment in Southwestern Ontario in order to understand current care pathways for future quality improvement initiatives.
The results of this study identified a number of different
findings about the current treatment of NMSC. For example,
wait times from referral to consultation for patients seen in
academic centres (15.3 + 12.7 weeks) was significantly longer
in comparison to those seen in the community (4.9 + 3.1
weeks), despite the fact that patient demographics and lesion
characteristics including size and aggressiveness were similar
between 2 groups. This suggests that there is opportunity for
more effective triage and sharing of clinical burden between
academic and community physicians. Interestingly, at academic centres, patients waited less time from consultation to
surgical excision (2.4 + 7.1 weeks), presumably because community surgeons wait for pathology results from biopsies prior
to lesion excision, whereas academic centres often only accept
biopsy-proven referrals. Additionally, academic centres have
more resources that allow for more procedural time, and more
manpower (such as residents) to perform these procedures.
Rates of negative peripheral and deep margins were similar
between both groups, suggesting that NMSC is being adequately treated in both community and academic setting.
Wait times in this study were longer than those found in a
cross-sectional study by Thind et al,11 which found patients
referred over a 5-year period in Southwestern Ontario waited
a median time of 50 days for consultation with a plastic surgeon. Another study by Barua et al12 cited the median wait
time between referral and consultation for plastic surgery in
Canada was 12.8 weeks in 2013, and the wait between consultation and treatment was a median of 14.7 weeks, resulting
in a period of 27.5 weeks between referral and treatment. In
Ontario, the median patient wait from referral to consultation
was 8 weeks, with an additional wait time of 7.8 weeks to
receive treatment. Although direct comparisons are difficult
as some of these studies included melanoma and NMSC, there
may be a trend toward increasing wait times due to increasing
volumes of skin cancer.
This current study identifies that patients seen in the academic centre lived significantly closer to clinic than those seen
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Figure 6. Location of lesion (values in percentages).

in the community. This was contradictory to our hypothesis
that patients may travel longer distances for care in a tertiary
care centre. One possibility for this unexpected outcome would
be that this study only captured distance travelled from a
patient’s home to the surgeon’s main office. This may be misleading as many community surgeons offer “satellite” clinic
services where physicians travel to various locations to complete consultations and treatments in rural settings, providing
increased convenience for patients. Additionally, the population surrounding academic centres is more condensed, so
patients may travel shorter distances overall.
Referral information provides an important component of
triaging care. Many referrals from primary care physicians to
community surgeons (82%) as well as academic surgeons
(92%) included a description of lesion location. It is important
for this information to be captured in referrals, to allow the
consulting surgeon to assess whether they treat that anatomic
area and plan the time required for consultation, or to direct the
referral elsewhere. For example, it may take 20 minutes to
conduct a consultation and perform excision for NMSC on a
back, whereas a lesion on a cosmetically sensitive area may
require additional time for the consult (to explain cosmetic or
functional risks) and treatment (longer procedure time to perform a complex repair). Interestingly, referrals to both cohorts
rarely described the size of the lesion (18% of community and
29% of academic referrals). This information is also vital in the
accurate triage of patients with NMSC. Larger lesion size is
correlated with increased morbidity, case complexity, and
rarely mortality.13 Incomplete data likely influence wait times
since consulting physicians are not being provided with the full
clinical patient history.
Another interesting finding is that the majority of referrals
sent to the academic centre included biopsy results of the lesion
prior to referral (78.6%), in comparison to 25.6% of those sent
to the community. This practice pattern likely serves as a
method of triage for academic surgeons who only accept
biopsy-proven referrals. On the other hand, community plastic
surgeons provide an important element of primary care and

screening of both benign and malignant lesions and therefore
may not view prior diagnosis as important. Understanding
referral patterns such as this will be important when future
quality improvement initiatives for NMSC commence.

Strengths and Limitations
To our knowledge, this is the first study that directly compared wait times for a common clinical problem between
academic and community surgeons in plastic surgery. There
are some limitations to our study, which may have influenced
our results. First, the study period was only limited to 3 years.
Additionally, the confounding factor that patients may have
been referred to another physician for biopsy, such as a dermatologist, prior to referral to a plastic surgeon has not been
accounted for. Further, a “patient-based incidence approach”
is used, which may underestimate the burden of NMSC in our
patient population.14

Conclusion
In conclusion, we have discovered patients are waiting longer
periods of time for consultation and treatment with academic
plastic surgeons in comparison to the community. Quality
improvement initiatives may look at methods of sharing the
clinical burden more equitably among those providing care to
patient with NMSC. Also, this study has identified there is
room for improvement in the referral process, such as standardizing referral forms to include information vital to the triage
of patients with NMSC. Specifically referring physicians
should aim to include critical information in their referrals,
including lesion location and size at minimum, and tumourspecific information, such as recurrent disease or actual biopsy
results when available. Further research is required across the
province and country to more accurately capture care pathways
for NMSC, but this study can serve as a pilot to begin the
quality improvement initiatives and optimize the care of this
patient population.
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